Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1998-11-19
2000-12-26
Carr, Deborah D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
554 79, 554 85, 554 88, 554 96, 514143, 514517, A01N 5710
Patent
active
061659975
ABSTRACT:
A pharmaceutical formulation for stimulating growth of Gram-positive Bacilli and increasing the acidity in vagina comprises sucrose and/or maltose, optionally with other sugars, viscous base, and anti-fungal and/or anti-bacterial agents.
REFERENCES:
patent: 4588578 (1986-05-01), Fountain et al.
patent: 4619794 (1986-10-01), Hauser
patent: 4897384 (1990-01-01), Janoff et al.
patent: 4923854 (1990-05-01), Tilcock et al.
patent: 4999199 (1991-03-01), Anaissie et al.
patent: 5135922 (1992-08-01), Vitale
patent: 5409704 (1995-04-01), Bally et al.
patent: 5434182 (1995-07-01), Isaacs et al.
patent: 5466714 (1995-11-01), Isaacs et al.
patent: 5478819 (1995-12-01), Tarpila et al.
patent: 5480877 (1996-01-01), Mosher, Jr.
patent: 5585106 (1996-12-01), Gristina et al.
patent: 5624958 (1997-04-01), Isaacs et al.
patent: 5648348 (1997-07-01), Fost et al.
Chem. Abstr., vol. 108, abstr. 200731, Gonzales et al., 1988.
John Pace et al., "Singal Transduction and Invasion of Epithelial Cells by S. typhimurium", Cell, vol. 72 (Feb. 26, 1993) pp. 505-514.
Barbara L. Angus, et al., "Outer Membrane Permeability in Pseudomonas aeruginosa: Comparison of a Wild-type with an Antibiotic-Supersusceptible Mutant", Antimicrobial Agents and Chemotherapy, vol. 21, No. 2 (Feb. 1982) pp. 299-309.
Hans G. Boman, "Antibacterial Peptides: Key Components Needed in Immunity", Cell, vol. 65 (Apr. 19, 1991) pp. 205-207.
Hans G. Boman, et al., "Cell-free immunity in Cecropia. A model system for antibacterial proteins" Eur. J. Biochem, vol. 201 (Feb. 1991) pp. 23-31.
Deb K. Chatterjee et al., "Genetic Rearrangements in Plasmids Specifying Total Degradation of Chlorinated Benzoic Acids", Mol. Gen. Genet., vol. 188 (1982) pp. 279-285.
P.S. Chen, et al., "Microdetermination of Phosphorus", Analytical Chemistry, vol. 28, No. 11 (Nov. 1956) pp. 1756-1758.
Peter Elsbach et al., "Separation and Purification of a Potent Bactericidal/Permeability-increasing Protein and a Closely Associated Phospholipase A2 from Rabbit Polymorphonuclear Leukocytes", Journal of Biological Chemistry, vol. 254, No. 21 (Nov. 10, 1979) pp. 11000-11009.
Birgit Giwereman et al., "Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed B-lactamase producing strains", Journal of Antimicrobial Chemotherapy, vol. 26 (1990) pp. 247-259.
J.R.W. Govan et al., "Microbial Pathogenesis in Cystic Fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia" Microbioligical Reviews, vol. 60, No. 3 (Sep. 1996) pp. 539-574.
Robert E.W. Hancock, "The bacterical outer membrane as a drug barrier", Trends in Microbiology, vol. 5, No. 1 (Jan. 1997) pp. 37-42.
Robert E.W. Hancock, et al., "Outer Membrane on Pseudomonas aeruginosa: Heat- and 2-Mercaptoethanol-Modifiable Proteins", Journal of Bacteriology, vol. 140, No. 3 (Dec. 1979) pp. 902-910.
Robert E.W. Hancock et al., "Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis: A Class of Serum-Sensitive, Nontypable Strains Deficient in Lipoposaccharide O Side Chains", Infection and Immunity, vol. 42, No. 1 (1983) pp. 170-177.
Robert E.W. Hancock, et al., "Involvment of the Outer Membrane in Gentamicin and Streptomycin Uptake and Killing in Pseudomonas aeruginosa", Antimicrobial Agents and Chemotherapy, vol. 19, No. 5 (May 1981) pp. 777-785.
Robert E.W. Hancock, et al., "Compounds Which Increase the Permeability of the Pseudomonas aeruginosa Outer Membrane", Antimicrobial Agents and Chemotherapy, vol. 26, No. 1 (Jul. 1984) pp. 48-52.
Robert I. Lehrer et al., "Antimicrobial Polypeptides of Human Neutrophils", Blood: Journal of The American Society of Hematology, vol. 76, No. 11 (Dec. 1990) pp. 2169-2181.
Robert I. Lehrer et al., "Defensins: Endogenous Antibiotic Peptides of Animal Cells", Cell, vol. 64 (Jan. 1991) pp. 229-230.
D.M. Livermore, "Clinical Significance of Beta-Lactamase Induction and Stable Derepression in Gram-Negative Rods", Eur. J. Clin. Microbiol, vol. 6, No. 4 (Aug. 1987) pp. 439-445.
B. Ojeniyi et al., "Prevalence and persistence of polyagglutinable Pseudomonas aeruginosa in isolates from cystic fibrosis patients", APMIS, vol. 99 (1991) pp. 187-195.
Svend Stenvang Pedersen et al., "Pseudomonas aeruginosaAlginate in Cystic Fibrosis Sputum and the Inflammatory Response", Infection and Immunity, vol. 58, No. 10 (Oct. 1990) pp.3363-3368.
Keith Poole et al., "Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa", Molecular Microbiology, vol. 21, No. 4 (1996) pp. 713-724.
Keith Poole et al., "Espression of the Multidrug Resistance Operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR Encodes a Regulator of Operon Expression", Antimicrobial Agents and Chemotherapy, vol. 40, No. 9 (Sep. 1996) pp. 2021-2028.
M.H. Richmond et al., "The B-Lactamases of Gram-Negative Bacteria and their Possible Physiological Role", Adv. Microbiol Physiol., vol. 9 (1973) pp. 31-88.
R.B. Sykes et al., "Resistance of Pseudomonas aeruginosa to Antimicrobial Drugs", Progress in Medicinal Chemistry, vol. 12 (1975) pp. 333-393.
Martti Vaara, "Agents That Increase the Permeability of the Outer Membrane", vol. 56, No. 3 (Sep. 1992) pp. 395-411.
Martti Vaara et al., "Polycations Sensitize Enteric Bacteria to Antibiotics", Antimicrobial Agents and Chemotherapy, vol. 24, No. 1 (Jul. 1983) pp. 107-113.
Petri Viljanen et al., "The Outer Membrane Permeability-Increasing Action of Deacylpolymyxins", The Journal of Antibiotics, vol. 44, No. 5 (May 1991) pp. 517-523.
Wendy A. Woodruff et al., "Construction and Characterization of Pseudomonas aeruginosa Protein F-Deficient Mutants after In Vitro and In Vivo Insertion Mutagenesis of the Cloned Gene", Journal of Bacteriology, vol. 170, No. 6 (Jun. 1988) pp. 2592-2598.
Fuminobu Yoshimura et al., Permeability of Pseudomonas aeruginosa Outer Membrane to Hydrophilic Solutes', Journal of Bacteriology, vol. 152, No. 2 (Nov. 1982) pp. 636-642.
Xin Zhou et al., "Isolation and Characterization of an Attenuated Strain of Pseudomonas aeruginosa AC869, a 3,5-Dichlorobenzoate Degrader", Applied and Environmental Microbiology, vol. 63, No. 4 (Apr. 1997) pp. 1389-1395.
Carl I. Price et al., "Liposome encapsulation: A method of enhancing the effectiveness of local antibiotics", Surgery, vol. 115, No. 4 (Apr. 1994) pp. 480-487.
Jacqueline Lagage et al., "Liposome-encapsulated antibiotics: preparation, drug release and antimicrobial activity against Pseudomonas aeruginosa", J. Microencapsulation, vol. 8, Nol. 1 (1991) pp. 53-61.
Hiroshi Nikaido, "Outer Membrane", Escherichia coli and Salmonella--Cellular and Molecular Biology, vol. 1, 2nd Ed. (19 ) pp. 29-47.
O. Ciofu et al., "Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center", APMIS, vol. 102 (1994) pp. 674-680.
Helen R. Revel, "Restriction of Nonglucosylated T-even Bacteriophage: Properties of Permissive Mutants of Escherichia coli B and K12", Virology, vol. 31 (1967) pp. 688-701.
Douglas S. Kernodle et al., "Comparative Prophylactic Efficacies of Ciproflosacin, Ofloxacin, Cefazolin, and Vancomycin in Experimental Model of Staphylococcal Wound Infection", Antimicrobial Agents and Chemotherapy, vol. 38, No. 6 (Jun. 1994) pp. 1325-1330.
Michael J. Preston et al., "Rapid and Sensitive Method for Evaluating Pseudomonas aeruginosa Virulence Factors during Corneal Infections in Mice", Infection and Immunity, vol. 63, No. 9 (Sep. 1995) pp. 3497-3501.
Cohen Paul S.
Krogfelt Karen A.
Laux David C.
Utley Maryjane
Carr Deborah D.
Statens Serum Institut
LandOfFree
Phospholipids having antimicrobial activity with or without the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phospholipids having antimicrobial activity with or without the , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phospholipids having antimicrobial activity with or without the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-994980